Holen Sie sich die Stockscreener-App
11.32
1.34%
0.15
Handel nachbörslich:
11.31
-0.010
-0.09%
Schlusskurs vom Vortag:
$11.17
Offen:
$11.22
24-Stunden-Volumen:
4.60M
Relative Volume:
0.98
Marktkapitalisierung:
$5.52B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
28.30
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+1.89%
1M Leistung:
-3.41%
6M Leistung:
-25.23%
1J Leistung:
-29.38%
1-Tages-Spanne:
$11.12
$11.46
1-Wochen-Bereich:
$10.20
$11.46
52-Wochen-Spanne:
$10.20
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
11.32 | 5.52B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
170.55 | 75.15B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.59 | 47.71B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.84 | 47.70B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.00 | 18.75B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.28 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Veterinary Pharmacovigilance Market Is Booming So Rapidly | Elanco, Norbrook, Bimeda - openPR
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Linscomb Wealth Inc. Sells 61,733 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Phocas Financial Corp. - MarketBeat
Truist Financial Corp Purchases 120,596 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Barclays Lowers Elanco Animal Health (NYSE:ELAN) Price Target to $19.00 - MarketBeat
Shareholder Rights Advocates at Levi & Korsinsky Investigate Elanco Animal Health Incorporated (ELAN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by Skylands Capital LLC - MarketBeat
Decoding Elanco Animal Health Inc (ELAN): A Strategic SWOT Insig - GuruFocus.com
ELANCO FRAUD ALERT: Elanco (NYSE:ELAN) Shareholders that Suffered Losses are Alerted to Contact BFA Law about Investigation into the Company for Securities Fraud - ACCESS Newswire
Elanco’s Earnings Call: Growth Amid Challenges - TipRanks
Elanco Animal Health (NYSE:ELAN) Price Target Cut to $17.00 by Analysts at UBS Group - MarketBeat
Is Elanco Animal Health Incorporated (ELAN) the Best Low Price Pharma Stock to Invest In Right Now? - Yahoo Finance
Elanco launches new line of dog supplements - Pet Food Processing
Leerink Partnrs Issues Negative Forecast for ELAN Earnings - MarketBeat
Illinois Municipal Retirement Fund Purchases 103,692 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Hardman Johnston Global Advisors LLC Acquires 288,160 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire
Cohen Capital Management Inc. Decreases Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco and Medgene Team Up to Combat Avian Influenza in Dairy Cattle - Zenopa
UBS Adjusts Price Target on Elanco Animal Health to $17 From $18, Keeps Buy Rating - Marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2024 Earnings Call Transcript - Insider Monkey
Elanco Animal Health: Promising Growth Amid FX Challenges and Strong Product Pipeline - TipRanks
Cautious Outlook for Elanco Animal Health Amid Lower EPS and EBITDA Projections - TipRanks
Elanco Animal Health Inc (ELAN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and ... - Yahoo Finance
Elanco Animal Health Inc (ELAN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and ... By GuruFocus - Investing.com Canada
Elanco Animal Health Reports 2024 Earnings and 2025 Outlook - TipRanks
Elanco Charting a Path to Growth Amid Headwinds: What Investors Should Know - Be3
Elanco’s Slow and Steady Transformation: An Opportunity in Disguise? - Jomfruland.net
Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff - Benzinga
Elanco's SWOT analysis: animal health stock poised for growth amid challenges - Investing.com India
Elanco's SWOT analysis: animal health stock poised for growth amid challenges By Investing.com - Investing.com South Africa
Elanco slips as forex headwinds weigh on outlook - MSN
Elanco’s SWOT analysis: animal health stock poised for growth amid challenges - Investing.com
Elanco Animal Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Elanco Animal Health Shares Struggle Amid Mixed Results - TipRanks
Elanco Animal Health (ELAN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Elanco Animal Health Inc SEC 10-K Report - TradingView
Elanco Animal Health Incorporated (ELAN) Q4 Earnings Miss Estimates - Yahoo Finance
Elanco Animal Health (ELAN) Q4 2024 Earnings Call Transcript - MSN
Elanco Animal Health Inc Reports Q4 2024 Revenue of $1,020 Milli - GuruFocus.com
Elanco (NYSE:ELAN) Surprises With Q4 Sales By Stock Story - Investing.com Canada
Elanco Animal Health's Q4 Adjusted Earnings Rise, Revenue Falls; 2025 Guidance Issued - Marketscreener.com
Elanco Animal Health reports Q4 earnings, misses estimates By Investing.com - Investing.com South Africa
Elanco Animal Health reports Q4 earnings, misses estimates - Investing.com India
BRIEF-Elanco Animal Health Q4 Revenue USD 1,020 Million Vs. IBES Estimate USD 1,010 Million - TradingView
Elanco (NYSE:ELAN) Surprises With Q4 Sales - Yahoo Finance
Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results - TradingView
Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle - PR Newswire
Stifel Nicolaus Cuts Elanco Animal Health (NYSE:ELAN) Price Target to $16.00 - MarketBeat
Elanco Animal Health Incorporated Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for Details- ELAN - ACCESS Newswire
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):